Making Moves: Tenet Healthcare Corp. (NYSE:THC), Hill-Rom Holdings (NYSE:HRC), Concert Pharmaceuticals (NASDAQ:CNCE), Gilead Sciences (NASDAQ:GILD)

PAR Technology Corporation (NYSE:PAR) shares moved up 1.19% in last trading session and ended the day at $5.10. PAR Gross Margin is 20.30% and its has a return on assets of -3.10%. PAR Technology Corporation (NYSE:PAR) quarterly performance is -14.72%.

PAR Technology Corporation (NYSE:PAR), a leading global provider of point-of-sale (POS) solutions to the restaurant industry, and its cloud-based Brink POS software are featured in an article in PC Magazine, “The Best Point-of-Sale Software of 2016.” The article reviews seven POS software solutions for the restaurant industry and features input from software users.

Tenet Healthcare Corp. (NYSE:THC) ended the last trading day at $24.21. Company weekly volatility is calculated as 6.62% and price to cash ratio as 5.36. Tenet Healthcare Corp. (NYSE:THC) showed a weekly performance of -7.17%.

Tenet Healthcare Corporation (NYSE:THC) plans to report results for its fourth quarter ended December 31, 2015 after the market close on Monday, February 22, 2016. The company will host a conference call the following morning, Tuesday, February 23rd, at 10 a.m. EST (9:00 a.m. CST) for management to discuss the results.

On 09 February, Hill-Rom Holdings, Inc. (NYSE:HRC) shares moved up 0.62% and was closed at $44.17. HRC EPS growth in last 5 year was -16.30%. Hill-Rom Holdings, Inc. (NYSE:HRC) year to date (YTD) performance is -8.09%.

On 1st February, Hill-Rom Holdings Inc. (NYSE:HRC) reported fiscal first-quarter profit of $4.8 million. The Batesville, Indiana-based company said it had profit of 7 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and amortization costs, came to 68 cents per share. The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 65 cents per share. The medical equipment maker posted revenue of $661.2 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $658.6 million.

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) shares moved down -0.15% in last trading session and ended the day at $13.29. CNCE has a return on assets of 11.50%. Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) quarterly performance is -39.45%.

TheStreet downgraded shares of Concert Pharmaceuticals Inc (NASDAQ:CNCE) from a hold rating to a sell rating in a report issued on Thursday, Marketbeat reports.

Gilead Sciences Inc. (NASDAQ:GILD) caters to the Healthcare space. It has a net profit margin of 55.50% and weekly performance is 5.49%. On the last day of trading company shares ended up at $87.25.

Gilead Sciences, Inc. (NASDAQ: GILD) announced webcasts from two investor conferences: the 18th Annual BIO CEO & Investor Conference and the Leerink Partners 5th Annual Global Healthcare Conference, both took place in New York. John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, participate in fireside chats at the BIO CEO conference on Tuesday, February 9 at 2:00 p.m. Eastern Time (ET) and the Leerink Partners conference on Wednesday, February 10 at 8:25 a.m. ET.